Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer.

Allott EH, Ebot EM, Stopsack KH, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Ahearn TU, Gerke TA, Downer MK, Rider JR, Freedland SJ, Lotan TL, Kantoff PW, Platz EA, Loda M, Stampfer MJ, Giovannucci E, Sweeney CJ, Finn SP, Mucci LA.

Clin Cancer Res. 2019 Nov 21. doi: 10.1158/1078-0432.CCR-19-2853. [Epub ahead of print]

PMID:
31754047
2.

Statin drugs and risk of advanced prostate cancer.

Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E.

J Natl Cancer Inst. 2006 Dec 20;98(24):1819-25.

PMID:
17179483
3.

A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.

Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA.

Eur Urol. 2019 Jul;76(1):33-40. doi: 10.1016/j.eururo.2018.09.041. Epub 2018 Oct 6.

PMID:
30301696
4.

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL.

J Natl Cancer Inst. 2015 Nov 27;108(2). pii: djv346. doi: 10.1093/jnci/djv346. Print 2016 Feb.

5.

Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study.

Chan JM, Kenfield SA, Paciorek A, Platz EA, Giovannucci EL, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1638-40. doi: 10.1158/1055-9965.EPI-15-0671. Epub 2015 Jul 19.

6.

Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.

Downer MK, Allard CB, Preston MA, Wilson KM, Kenfield SA, Chan JM, Mucci LA, Giovannucci E, Stampfer MJ.

Eur Urol Oncol. 2019 Mar;2(2):126-134. doi: 10.1016/j.euo.2018.07.002. Epub 2018 Jul 31.

PMID:
31017087
7.

Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer.

Hashim D, Gonzalez-Feliciano AG, Ahearn TU, Pettersson A, Barber L, Pernar CH, Ebot EM, Isikbay M, Finn SP, Giovannucci EL, Lis RT, Loda M, Parmigiani G, Lotan T, Kantoff PW, Mucci LA, Graff RE.

Int J Cancer. 2019 Jul 18. doi: 10.1002/ijc.32577. [Epub ahead of print]

PMID:
31318977
8.

Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study.

Mondul AM, Joshu CE, Barber JR, Prizment AE, Bhavsar NA, Selvin E, Folsom AR, Platz EA.

Cancer Prev Res (Phila). 2018 Dec;11(12):779-788. doi: 10.1158/1940-6207.CAPR-17-0396. Epub 2018 Oct 16.

9.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.

PMID:
28753762
10.

Statin use, high cholesterol and prostate cancer progression; results from HCaP-NC.

Allott EH, Farnan L, Steck SE, Song L, Arab L, Su LJ, Fontham ETH, Mohler JL, Bensen JT.

Prostate. 2018 Aug;78(11):857-864. doi: 10.1002/pros.23644. Epub 2018 May 1.

PMID:
29717502
11.

Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study.

Platz EA, Drake CG, Wilson KM, Sutcliffe S, Kenfield SA, Mucci LA, Stampfer MJ, Willett WC, Camargo CA Jr, Giovannucci E.

Int J Cancer. 2015 Aug 15;137(4):949-58. doi: 10.1002/ijc.29463. Epub 2015 Feb 27.

12.

Statin use and prostate cancer risk in a large population-based setting.

Boudreau DM, Yu O, Buist DS, Miglioretti DL.

Cancer Causes Control. 2008 Sep;19(7):767-74. doi: 10.1007/s10552-008-9139-4. Epub 2008 Mar 6.

13.

Statin use, hyperlipidemia, and risk of glioma.

Cote DJ, Rosner BA, Smith-Warner SA, Egan KM, Stampfer MJ.

Eur J Epidemiol. 2019 Nov;34(11):997-1011. doi: 10.1007/s10654-019-00565-8. Epub 2019 Sep 26.

PMID:
31559554
14.

Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.

Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Carcinogenesis. 2018 Dec 31;39(12):1431-1437. doi: 10.1093/carcin/bgy112.

15.

Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications.

Van Rompay MI, Solomon KR, Nickel JC, Ranganathan G, Kantoff PW, McKinlay JB.

Eur J Cancer. 2019 May;112:118-126. doi: 10.1016/j.ejca.2018.11.033. Epub 2019 Mar 6.

PMID:
30850323
16.

5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer.

Preston MA, Wilson KM, Markt SC, Ge R, Morash C, Stampfer MJ, Loda M, Giovannucci E, Mucci LA, Olumi AF.

JAMA Intern Med. 2014 Aug;174(8):1301-7. doi: 10.1001/jamainternmed.2014.1600.

17.

Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.

Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR.

Eur Urol. 2018 Nov;74(5):668-675. doi: 10.1016/j.eururo.2018.08.020. Epub 2018 Sep 1.

PMID:
30181067
18.

Statins and prostate cancer diagnosis and grade in a veterans population.

Farwell WR, D'Avolio LW, Scranton RE, Lawler EV, Gaziano JM.

J Natl Cancer Inst. 2011 Jun 8;103(11):885-92. doi: 10.1093/jnci/djr108. Epub 2011 Apr 15.

19.

Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.

Downer MK, Kenfield SA, Stampfer MJ, Wilson KM, Dickerman BA, Giovannucci EL, Rimm EB, Wang M, Mucci LA, Willett WC, Chan JM, Van Blarigan EL.

J Clin Oncol. 2019 Jun 10;37(17):1499-1511. doi: 10.1200/JCO.18.02462. Epub 2019 Apr 26.

PMID:
31026211
20.

Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.

Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.

BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.

Supplemental Content

Support Center